Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Celiac Disease | 32 | 2024 | 785 | 9.400 |
Why?
|
Glutens | 11 | 2023 | 230 | 4.200 |
Why?
|
Diet, Gluten-Free | 12 | 2023 | 271 | 3.450 |
Why?
|
Duodenum | 6 | 2023 | 483 | 2.000 |
Why?
|
Transglutaminases | 6 | 2023 | 194 | 1.470 |
Why?
|
Immunoglobulin A | 6 | 2023 | 992 | 1.050 |
Why?
|
Intestinal Mucosa | 8 | 2023 | 3036 | 0.910 |
Why?
|
Metagenomics | 3 | 2021 | 428 | 0.890 |
Why?
|
Metabolome | 4 | 2023 | 895 | 0.840 |
Why?
|
Food Hypersensitivity | 2 | 2019 | 622 | 0.780 |
Why?
|
Immunologic Tests | 1 | 2020 | 103 | 0.720 |
Why?
|
Metabolomics | 3 | 2021 | 1484 | 0.590 |
Why?
|
Milk, Human | 1 | 2021 | 490 | 0.570 |
Why?
|
Endoscopy, Gastrointestinal | 2 | 2023 | 868 | 0.530 |
Why?
|
Intestinal Diseases | 1 | 2020 | 530 | 0.530 |
Why?
|
GTP-Binding Proteins | 2 | 2017 | 970 | 0.520 |
Why?
|
Autoimmunity | 3 | 2021 | 1349 | 0.490 |
Why?
|
Environment | 1 | 2020 | 1124 | 0.480 |
Why?
|
Serologic Tests | 3 | 2020 | 374 | 0.410 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 2012 | 0.380 |
Why?
|
Budesonide | 2 | 2022 | 154 | 0.370 |
Why?
|
Intestines | 2 | 2016 | 1924 | 0.350 |
Why?
|
Monitoring, Physiologic | 1 | 2017 | 1738 | 0.350 |
Why?
|
Child | 17 | 2024 | 77709 | 0.290 |
Why?
|
Inflammation | 5 | 2023 | 10638 | 0.280 |
Why?
|
Bacteria | 1 | 2016 | 2114 | 0.260 |
Why?
|
Biopsy | 4 | 2023 | 6756 | 0.250 |
Why?
|
Humans | 41 | 2024 | 744343 | 0.230 |
Why?
|
Haptoglobins | 1 | 2024 | 165 | 0.220 |
Why?
|
Evidence-Based Medicine | 1 | 2014 | 3610 | 0.210 |
Why?
|
Child, Preschool | 7 | 2024 | 41006 | 0.200 |
Why?
|
Genetic Testing | 1 | 2014 | 3444 | 0.200 |
Why?
|
Thioctic Acid | 1 | 2020 | 23 | 0.190 |
Why?
|
Methane | 1 | 2020 | 51 | 0.190 |
Why?
|
Typhoid Fever | 1 | 2022 | 197 | 0.190 |
Why?
|
Prospective Studies | 7 | 2023 | 53288 | 0.190 |
Why?
|
Infant | 6 | 2024 | 35136 | 0.180 |
Why?
|
HLA-DQ Antigens | 1 | 2020 | 210 | 0.180 |
Why?
|
Bacteroides | 1 | 2020 | 161 | 0.180 |
Why?
|
Longitudinal Studies | 4 | 2021 | 13989 | 0.180 |
Why?
|
Addison Disease | 1 | 2020 | 48 | 0.180 |
Why?
|
Periodontal Diseases | 1 | 2023 | 449 | 0.180 |
Why?
|
Lymphopenia | 1 | 2022 | 285 | 0.180 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2014 | 3336 | 0.170 |
Why?
|
Mass Screening | 1 | 2015 | 5255 | 0.170 |
Why?
|
Protein Precursors | 1 | 2024 | 1154 | 0.170 |
Why?
|
Genomics | 4 | 2023 | 5720 | 0.170 |
Why?
|
Leukocyte L1 Antigen Complex | 1 | 2018 | 88 | 0.160 |
Why?
|
Cross-Sectional Studies | 5 | 2023 | 25043 | 0.160 |
Why?
|
Duodenoscopy | 1 | 2017 | 52 | 0.150 |
Why?
|
Metabolic Networks and Pathways | 1 | 2021 | 783 | 0.140 |
Why?
|
Vomiting | 1 | 2020 | 636 | 0.140 |
Why?
|
Abdominal Pain | 1 | 2023 | 1063 | 0.140 |
Why?
|
Diarrhea | 1 | 2023 | 1348 | 0.130 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2023 | 1130 | 0.130 |
Why?
|
Infant, Newborn | 3 | 2021 | 25625 | 0.130 |
Why?
|
Nutritional Status | 1 | 2023 | 1609 | 0.130 |
Why?
|
Down Syndrome | 1 | 2023 | 880 | 0.130 |
Why?
|
Intestine, Small | 2 | 2017 | 1241 | 0.120 |
Why?
|
Medical Records | 1 | 2019 | 1413 | 0.120 |
Why?
|
Retrospective Studies | 6 | 2023 | 77449 | 0.110 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 3870 | 0.110 |
Why?
|
Immunity, Mucosal | 1 | 2016 | 490 | 0.110 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2016 | 341 | 0.110 |
Why?
|
Case-Control Studies | 2 | 2021 | 21746 | 0.110 |
Why?
|
Cesarean Section | 1 | 2020 | 1365 | 0.100 |
Why?
|
Child Development | 1 | 2023 | 2223 | 0.100 |
Why?
|
Treatment Failure | 1 | 2017 | 2618 | 0.100 |
Why?
|
Predictive Value of Tests | 2 | 2017 | 15076 | 0.100 |
Why?
|
Adaptive Immunity | 1 | 2016 | 713 | 0.100 |
Why?
|
Female | 13 | 2024 | 380194 | 0.100 |
Why?
|
Anti-Inflammatory Agents | 1 | 2020 | 1790 | 0.090 |
Why?
|
Disease Management | 1 | 2020 | 2459 | 0.090 |
Why?
|
Forkhead Transcription Factors | 1 | 2017 | 1613 | 0.090 |
Why?
|
Antibodies | 1 | 2017 | 2460 | 0.080 |
Why?
|
Male | 11 | 2024 | 350118 | 0.080 |
Why?
|
HLA Antigens | 1 | 2014 | 1381 | 0.080 |
Why?
|
Adolescent | 6 | 2023 | 85781 | 0.080 |
Why?
|
Immunoglobulin G | 2 | 2023 | 4560 | 0.080 |
Why?
|
Young Adult | 4 | 2020 | 56430 | 0.080 |
Why?
|
Interferon-gamma | 1 | 2017 | 3206 | 0.080 |
Why?
|
Diagnosis, Differential | 3 | 2020 | 12959 | 0.080 |
Why?
|
Stress, Psychological | 1 | 2023 | 4245 | 0.080 |
Why?
|
Haplotypes | 1 | 2014 | 2779 | 0.080 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2020 | 4386 | 0.080 |
Why?
|
Hypersensitivity | 1 | 2016 | 1102 | 0.070 |
Why?
|
Overweight | 1 | 2018 | 2371 | 0.070 |
Why?
|
Host-Pathogen Interactions | 1 | 2016 | 1477 | 0.070 |
Why?
|
Immune Tolerance | 1 | 2016 | 2258 | 0.070 |
Why?
|
Diabetes Complications | 1 | 2014 | 1359 | 0.070 |
Why?
|
Double-Blind Method | 1 | 2020 | 12026 | 0.070 |
Why?
|
Massachusetts | 1 | 2019 | 8663 | 0.070 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14722 | 0.060 |
Why?
|
Obesity | 2 | 2018 | 12745 | 0.060 |
Why?
|
Incidence | 2 | 2022 | 20947 | 0.060 |
Why?
|
Adult | 8 | 2023 | 214055 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 2 | 2016 | 17446 | 0.060 |
Why?
|
Risk Factors | 3 | 2020 | 72290 | 0.060 |
Why?
|
Patient Compliance | 1 | 2014 | 2684 | 0.060 |
Why?
|
Epigenesis, Genetic | 1 | 2017 | 3647 | 0.060 |
Why?
|
Gliadin | 1 | 2023 | 79 | 0.060 |
Why?
|
Cohort Studies | 2 | 2023 | 40561 | 0.050 |
Why?
|
Prevalence | 1 | 2019 | 15226 | 0.050 |
Why?
|
Salmonella | 1 | 2022 | 129 | 0.050 |
Why?
|
Cytokines | 1 | 2017 | 7322 | 0.050 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2016 | 2425 | 0.050 |
Why?
|
Psychotic Disorders | 1 | 2016 | 3046 | 0.050 |
Why?
|
Bangladesh | 1 | 2022 | 687 | 0.050 |
Why?
|
Signal Transduction | 2 | 2020 | 23403 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39050 | 0.040 |
Why?
|
Primary Health Care | 1 | 2015 | 4558 | 0.040 |
Why?
|
Pregnancy | 1 | 2020 | 29144 | 0.040 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 2020 | 349 | 0.040 |
Why?
|
Phenotype | 1 | 2016 | 16365 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2015 | 19905 | 0.040 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2022 | 612 | 0.040 |
Why?
|
Weight Loss | 2 | 2020 | 2622 | 0.040 |
Why?
|
Avitaminosis | 1 | 2016 | 34 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15540 | 0.030 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2017 | 310 | 0.030 |
Why?
|
Animals | 3 | 2020 | 168757 | 0.030 |
Why?
|
Autoantibodies | 1 | 2023 | 2035 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2022 | 2309 | 0.030 |
Why?
|
Anti-Bacterial Agents | 2 | 2024 | 7181 | 0.030 |
Why?
|
Algorithms | 1 | 2014 | 13881 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 1 | 2022 | 1838 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 4933 | 0.030 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2016 | 365 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2017 | 1730 | 0.030 |
Why?
|
Cholesterol, HDL | 1 | 2018 | 1814 | 0.030 |
Why?
|
Middle Aged | 3 | 2020 | 213383 | 0.030 |
Why?
|
Triglycerides | 1 | 2018 | 2454 | 0.020 |
Why?
|
Th17 Cells | 1 | 2017 | 766 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2017 | 63114 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2022 | 2958 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2017 | 1836 | 0.020 |
Why?
|
Down-Regulation | 1 | 2017 | 3002 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2023 | 13033 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10943 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2023 | 7279 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2023 | 10180 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2017 | 2988 | 0.010 |
Why?
|
Blood Pressure | 1 | 2018 | 8554 | 0.010 |
Why?
|
Body Mass Index | 1 | 2018 | 12720 | 0.010 |
Why?
|
Aged | 1 | 2017 | 163280 | 0.000 |
Why?
|
Concepts
(145)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(40)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_